DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$7.49
+0.07 (+0.94%)
Open$7.47
Previous Close$7.42
Day High$7.76
Day Low$7.39
52W High$9.62
52W Low$3.53
Volume—
Avg Volume274.9K
Market Cap200.39M
P/E Ratio—
EPS$-2.80
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+309.7% upside
Current
$7.49
$7.49
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 71.47M | 64.43M | 15.69M |
| Net Income | -95,375,248 | -77,380,080 | 557.5K |
| Profit Margin | -133.5% | -126.8% | 3.6% |
| EBITDA | -105,787,896 | -90,596,323 | 726.6K |
| Free Cash Flow | — | — | 441.5K |
| Rev Growth | +10.9% | +10.9% | -7.6% |
| Debt/Equity | 0.24 | 0.24 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |